Navigation Links
Flagship Global Health Will Host Investor Conference Call on Thursday, November 29, 2007 at 2:00 PM EST
Date:11/26/2007

NEW YORK, Nov. 26 /PRNewswire-FirstCall/ -- Flagship Global Health, Inc. (OTC Bulletin Board: FGHH) will hold a conference call at 2:00 PM EST, Thursday, November 29, 2007. Mr. Fred Nazem, Chairman, and Mr. John Flood III, CEO of Flagship Global Health will host the investor call and will be giving a detailed update on the progress that the Company has made in the past quarter as well as what is anticipated in the near future.

The dial in number is toll free, (866) 566-1240 (domestic) and (702) 495- 1185 (International), with a Conference Call ID of 25786998. Participants should call in a few minutes before 2:00 PM EST. In order to join this conference call, participants will be required to provide the Conference ID Number listed above. Re-broadcast of the conference call will be available on Flagship Global Health's website, http://www.flagshipglobalhealth.com, within a day or two after the conference call.


'/>"/>
SOURCE Flagship Global Health, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Flagship Global Health Hires Health Care Veteran Larsen to Head Marketing and Sales
2. John H. Flood III Named as CEO of Flagship Global Health, Inc.
3. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
4. Tata Consultancy Services to Support Roches Global Capacity Building Initiative
5. Global Latex Conference to Showcase Vytex(TM) NRL
6. Mylan Announces Appointment of David A. Lillback as Senior Vice President and Global Head of Human Resources
7. Creative Technology Services Enhances its Global Competitiveness with Additional Regulatory Certifications
8. Briefing on a new Web resource to address global drinking water crisis
9. MDS Pharma Services Wins Award for Management of Global Malaria Trial
10. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
11. Resonant Medical Appoints New Vice President of Global Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 13, 2017 , ... The American Board of Family Medicine's (ABFM) Board of ... Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will serve ... Puffer’s retirement at the end of 2018. Upon assuming the role of President and ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along ... updates for the primary prevention of cardiovascular diseases during the 15th Annual ...
(Date:10/13/2017)... ... , ... Many families have long-term insurance that covers care for a family ... for care if the client has a cognitive impairment diagnosis. , “What this ... often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, owner ...
(Date:10/13/2017)... Milford, NJ (PRWEB) , ... October 13, 2017 , ... ... weekend at scenic Alexandria Park in Milford, NJ. This free event, sponsored by ... and physical activity. The fun run is geared towards children of all ages; ...
(Date:10/13/2017)... ... 2017 , ... Coveros, a leader in agile coaching services ... by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile Transformation ... Agile methodologies in a consistent and high value manner across CMS programs. Coveros ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... MIAMI , Sept. 27, 2017  Commended for their ... recent notable awards. Ranked as number one in the South ... ninth time in Inc. 5000 yearly list, the national specialty ... CEO, Armando Bardisa will soon be honored by ... Set to receive his award ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology: